National Center for Advancing Translational Sciences |

Double circle infographic with the outer circle containing 4 evenly divided sections called: Better Treatments, Novel Chemistries, Approved Drugs, and Innovative Technologies. Each section contains 4 icons associated with the name of each quarter. The inner circle contains the words Planning, Prototype Delivery, and Prototype Development. At the center of the double circle are the words Integrated Platform.

Apply Now: The ASPIRE Reduction-to-Practice Challenge is Open

This prize competition will reward a working prototype of a comprehensive integrated platform with the goal of developing more effective and nonaddictive pain medicine.

Learn More

Our focus is to advance the science of translation, which is the process of turning observations into interventions to improve health.

We collaborate with researchers, the public and other stakeholder groups to design new approaches and technologies that ultimately will deliver more treatments to more people more quickly. Read more

In the Spotlight See more spotlights

Scanning electron microscope image of SARS-CoV-2.

Stay Up to Date with NCATS’ Response to COVID-19

Subscribe to the NCATS Newsletter

Illustration of a cytokine storm response to infection with the new coronavirus SARS-CoV-2.

Find COVID-19 Clinical Trials Supported by NIH, Including NCATS

CTSA Program Hubs Working with Communities to Address COVID-19

Picture of Zika-infected mouse brain from NIH study that looked for effective anti-viral treatments.

A New Collaborative Study Suggests Commonly Used Antibiotic May Help Combat Zika Infection

NCATS Patent Book Showcases Opportunities for New Partnerships

International Space Station U.S. National Lab’s Expedition 59 crewmember David Saint-Jacques with the Massachusetts Institute of Technology’s and TechShot, Inc’s cartilage-bone-synovium tissue chips in space.

Trio of Tissue Chips in Space to Explore Osteoarthritis and Muscle Diseases

Female post-doctoral fellow examines data from high-throughput screens in one of NCATS’ laboratories.

Apply: New Translational Science Interagency Fellowship Co-Sponsored by NCATS and FDA

An image of a virus delivering a gene into a cell.

PaVe-GT: Creating a Gene Therapy Playbook

Director's Corner

Christopher P. Austin, M.D.

November Director’s Message

ACTIVating translational science to treat COVID-19

A particularly serious complication of COVID-19 is the “cytokine storm,” an overreaction of the body’s immune system. To evaluate if temporarily suppressing this response could save lives, NCATS is coordinating the ACTIV-1 Immune Modulator Phase 3 clinical trial.

Read Full Message

In the Spotlight See more spotlights

Director's Corner

November Director’s Message

ACTIVating translational science to treat COVID-19

Resources For You

For Researchers

For the Public